1. Home
  2. WNEB vs XOMA Comparison

WNEB vs XOMA Comparison

Compare WNEB & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western New England Bancorp Inc.

WNEB

Western New England Bancorp Inc.

HOLD

Current Price

$12.33

Market Cap

258.3M

Sector

Finance

ML Signal

HOLD

Logo XOMA Corporation

XOMA

XOMA Corporation

HOLD

Current Price

$27.26

Market Cap

308.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WNEB
XOMA
Founded
1853
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.3M
308.6M
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
WNEB
XOMA
Price
$12.33
$27.26
Analyst Decision
Hold
Strong Buy
Analyst Count
2
5
Target Price
$12.50
$60.60
AVG Volume (30 Days)
64.8K
110.4K
Earning Date
04-21-2026
03-18-2026
Dividend Yield
2.26%
N/A
EPS Growth
33.93
N/A
EPS
0.75
N/A
Revenue
$44,000.00
N/A
Revenue This Year
N/A
$76.93
Revenue Next Year
$5.61
$29.28
P/E Ratio
$16.44
$29.64
Revenue Growth
N/A
N/A
52 Week Low
$7.63
$18.40
52 Week High
$14.52
$39.92

Technical Indicators

Market Signals
Indicator
WNEB
XOMA
Relative Strength Index (RSI) 34.39 56.60
Support Level $12.07 $23.92
Resistance Level $12.68 $27.70
Average True Range (ATR) 0.42 1.57
MACD -0.03 0.10
Stochastic Oscillator 21.60 48.94

Price Performance

Historical Comparison
WNEB
XOMA

About WNEB Western New England Bancorp Inc.

Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.

About XOMA XOMA Corporation

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

Share on Social Networks: